NCI's SEER registries indicates many node-positive breast cancer patients can avoid chemo
Genomic Health announced publication of results from the NCI's Surveillance, Epidemiology, and End Results Registry in the peer-reviewed journal Breast Cancer Research and Treatment, reconfirming the value of the Oncotype DX Breast Recurrence Score® in guiding chemotherapy treatment decisions. March 24, 2017